QSAR modeling of HIV-1 reverse transcriptase inhibitor 2-amino-6- arylsulfonylbenzonitriles and congeners using molecular connectivity and E-state parameters

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 4, 2004, Pages 745-754

  Roy, Kunal ^a   Leonard, J Thomas ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZONITRILE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SULFONE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN; CONTROLLED STUDY; DISPERSION; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULE; MULTIPLE REGRESSION; QUALITY CONTROL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0842283490     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.11.009     Document Type: Article

References (56)

1. http://www.avert.org/worldstats.htm .
2. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.C., Montagnier L. Nature. 312:1984;767.
3. Kilby J.M., Eron J.J. N. Eng. J. Med. 348:2003;2228.
4. Clapham P.R., McKnight A. J. Gen. Virol. 83:2002;1809.
5. Hoxie J.A., LaBranche C.C., Endres M.J., Turner J.D., Berson J.F., Doms R.W., Matthews T.J. J. Reprod. Immunol. 41:1998;197.
6. Garg R., Gupta S.P., Gao H., Babu M.S., Debnath A.K., Hansch C. Chem. Rev. 99:1999;3525.
7. Douali L., Villemin D., Cherqaoui D. Curr. Pharm. Des. 9:2003;1817.
8. Mager P.P. Curr. Med. Chem. 10:2003;1643.
9. Douali L., Villemin D., Cherqaoui D. J. Chem. Inf. Comput. Sci. 43:2003;1200.
10. Bazoui H., Zahouily M., Boulajaaj S., Sebti S., Zakarya D. SAR. QSAR. Environ. Res. 13:2002;567.
11. Jalali-Heravi M., Parastar F. J. Chem. Inf. Comput. Sci. 40:2000;147.
12. Luco J.M., Ferretti F.H. J. Chem. Inf. Comput. Sci. 37:1997;392.
13. Hannongbua S., Lawtrakul L., Limtrakul J. J. Comput. Aided Mol. Des. 10:1996;145.
14. Pungpo P., Hannongbua S., Wolschann P. Curr. Med. Chem. 10:2003;1661.
15. Hannongbua S., Nivesanond K., Lawtrakul L., Pungpo P., Wolschann P. J. Chem. Inf. Comput. Sci. 41:2001;848.
16. Xie H.P., Jiang J.H., Cui H., Shen G.L., Yu R.Q. Comput. Chem. 26:2002;591.
17. Huuskonen J.J. Chem. Inf. Comput. Sci. 41:2001;425.
18. Hannongbua S., Pungpo P., Limtrakul J., Wolschann P. J. Comput. Aided Mol. Des. 13:1999;563.
19. Makhija M.T., Kulkarni V.M. J. Comput. Aided Mol. Des. 16:2002;181.
20. Pungpo P., Hannongbua S. J. Mol. Graph. Model. 18:2000;581.
21. Debnath A.K. J. Med. Chem. 42:1999;249.
22. Debnath A.K. J. Chem. Inf. Comput. Sci. 38:1998;761.
23. Debnath A.K., Jiang S., Strick N., Lin K., Haberfield P., Neurath A.R. J. Med. Chem. 37:1994;1099.
24. Huang X., Xu L., Luo X., Fan K., Ji R., Pei G., Chen K., Jiang H. J. Med. Chem. 45:2002;333.
25. Makhija M.T., Kulkarni V.M. J. Comput. Aided Mol. Des. 15:2001;961.
26. Gayathri P., Pande V., Sivakumar R., Gupta S.P. Bioorg. Med. Chem. 9:2001;3059.
27. Olivero-Verbel J., Pacheco-Londono L. J. Chem. Inf. Comput. Sci. 42:2002;1241.
28. Buolamwini J.K., Raghavan K., Fesen M.R., Pommier Y., Kohn K.W., Weinstein J.N. Pharm. Res. 13:1996;1892.
29. Makhija M.T., Kulkarni V.M. Bioorg. Med. Chem. 10:2002;1483.
30. Knaggs M.H., McGuigan C., Harris S.A., Heshmati P., Cahard D., Gilbert I.H., Balzarini J. Bioorg. Med. Chem. Lett. 10:2000;2075.
31. Siddiqui A.Q., McGuigan C., Ballatore C., Zuccotto F., Gilbert I.H., De Clercq E., Balzarini J. J. Med. Chem. 42:1999;4122.
32. Font M., Monge A., Ruiz I., Heras B. Drug Des. Discov. 14:1997;259.
33. Joao H.C., De Vreese K., Pauwels R., De Clercq E., Henson G.W., Bridger G.J. J. Med. Chem. 38:1995;3865.
34. Gupta S.P. Prog. Drug Res. 58:2002;223.
35. Scozzafava A., Casini A., Supuran C.T. Curr. Med. Chem. 9:2002;1167.
36. Scozzafava A., Owa T., Mastrolorenzo A., Supuran C.T. Curr. Med. Chem. 10:2003;925.
37. Leonard, J. T., Roy, K. QSAR Comb. Sci. 2003, in press.
38. Chan J.H., Hong J.S., Hunter R.N. III, Orr G.F., Cowan J.L., Sherman D.L., Sparks S.M., Reitter B.E., Andrews C.W. III, Hazen R.J., St Clair M., Boone L.R., Ferris R.G., Creech K.L., Roberts G.B., Short S.A., Weaver K., Ott R.J., Ren J., Hopkins A., Stuart D.I., Stammers D.K. J. Med. Chem. 44:2001;1866.
39. Hall L.H., Mohney B., Kier L.B. Quant. Struct-Act. Relat. 10:1991;43.
40. Kier L.B., Hall L.H. Pharm. Res. 7:1990;801.
41. Kier L.B., Hall L.H. J. Pharm. Sci. 70:1981;583.
42. Hall L.H., Mohney B., Kier L.B. Quant. Struct-Act. Relat. 12:1993;44.
43. Kier, L. B.; and Hall, L. H. In Advances in Drug Research; Testa, B., Ed.; Academic Press: New York, 1992; Vol. 22, p 1.
44. Kier L.B., Hall L.H. Molecular Structure Description: The Electrotopological State. 1999;Academic Press, San Diego.
45. Rose K., Hall L.H. SAR QSAR Environ. Res. 14:2003;113.
46. Robert D., Carbo-Dorca R. SAR QSAR Environ. Res. 10:1999;401.
47. Roy K., Pal D.K., Sengupta C. Drug Des. Discov. 17:2001;207.
48. Roy K., De A.U., Sengupta C. Drug Des. Discov. 18:2002;33.
49. Roy K., Chakraborty S., Saha A. Bioorg. Med. Chem. Lett. 13:2003;3753.
50. Maw H.H., Hall L.H. J. Chem. Inf. Comput. Sci. 42:2002;290.
51. Kier L.B., Hall L.H. Molecular Connectivity in Chemistry and Drug Research. 1976;Academic Press, New York.
52. Kier L.B., Hall L.H. Molecular Connectivity in Structure-Activity Analysis. 1986;Research Studies Press, Letchworth.
53. The GW-BASIC programs ELECTRO1, RRR98, KRPRES1 and KRPRES2 were developed by Kunal Roy and standardized on known data sets.
54. Snedecor, G. W.; Cochran, W. G. In Statistical Methods; Oxford and IBH Publishing Co. Pvt. Ltd: New Delhi, 1967; p 381.
55. Wold, S.; Eriksson, L. In Chemometric Methods in Molecular Design; van de Waterbeemd, H., Ed.; VCH: Weinheim, 1995; pp 312.
56. Debnath, A. K. In Combinatorial Library Design and Evaluation; Ghose, A. K.; Viswanadhan, V. N., Eds.; Marcel Dekker, Inc: New York, 2001; p 73.